Pala Melike, Castelein Martijn G, Dewaele Camille, Roelants Sophie L K W, Soetaert Wim K, Stevens Christian V
SynBioC, Department of Green Chemistry and Technology, Faculty of Bioscience Engineering, Ghent University, Ghent, Belgium.
Department of Biotechnology, Centre for Industrial Biotechnology and Biocatalysis (InBio.be), Faculty of Bioscience Engineering, Ghent University, Ghent, Belgium.
Front Bioeng Biotechnol. 2024 Feb 14;12:1347185. doi: 10.3389/fbioe.2024.1347185. eCollection 2024.
Sophorolipids, glycolipid biosurfactants derived from microorganisms such as , possess distinctive surface-active and bioactive properties, holding potential applications in cosmetics, pharmaceuticals and bioremediation. However, the limited structural variability in wild-type sophorolipids restricts their properties and applications. To address this, metabolic engineering efforts have allowed to create a portfolio of molecules. In this study, we went one step further by chemically modifying microbially produced sophorosides, produced by an engineered Twenty-four new sophoroside derivatives were synthesized, including sophoroside amines with varying alkyl chain lengths (ethyl to octadecyl) on the nitrogen atom and their corresponding quaternary ammonium salts. Additionally, six different microbially produced glycolipid biosurfactants were hydrogenated to achieve fully saturated lipid tails. These derivatives, along with microbially produced glycolipids and three benchmark biosurfactants (di-rhamnolipids, alkyl polyglucosides, cocamidopropyl betaine), were assessed for antimicrobial activity against bacteria () and yeast (). Results indicated that microbially produced glycolipids, such as bola sophorosides, acidic sophorolipids and acidic glucolipids exhibit selective antimicrobial activity against the test organisms. Conversely, lactonic sophorolipids, sophoroside amines and quaternary ammonium salts display a broad antimicrobial activity. and derivatives exhibit the lowest minimal inhibitory concentrations, ranging from 0.014 to 20.0 mg mL. This study demonstrates the potential synergy of thoughtful biotechnology and targeted chemistry to precisely tailor glycolipid biosurfactants to meet specific requirements across applications.
槐糖脂是一种源自微生物(如 )的糖脂类生物表面活性剂,具有独特的表面活性和生物活性,在化妆品、制药和生物修复领域具有潜在应用价值。然而,野生型槐糖脂的结构变异性有限,限制了其性能和应用。为了解决这一问题,代谢工程的努力使得能够创建一系列分子。在本研究中,我们更进一步,通过化学修饰由工程化 生产的微生物产生的槐糖苷。合成了24种新的槐糖苷衍生物,包括氮原子上具有不同烷基链长度(从乙基到十八烷基)的槐糖苷胺及其相应的季铵盐。此外,对六种不同的微生物产生的糖脂类生物表面活性剂进行氢化以实现脂质尾部完全饱和。这些衍生物,连同微生物产生的糖脂和三种基准生物表面活性剂(二鼠李糖脂、烷基多聚葡萄糖苷、椰油酰胺丙基甜菜碱),被评估对细菌( )和酵母( )的抗菌活性。结果表明,微生物产生的糖脂,如双槐糖苷、酸性槐糖脂和酸性葡糖脂对测试生物体表现出选择性抗菌活性。相反,内酯型槐糖脂、槐糖苷胺和季铵盐表现出广泛的抗菌活性。 和 衍生物表现出最低的最低抑菌浓度,范围为0.014至20.0 mg/mL。本研究证明了精心设计的生物技术和有针对性的化学方法相结合的潜在协同作用,能够精确定制糖脂类生物表面活性剂以满足不同应用的特定要求。